Viscira Expands Interactive Solutions to Reduce Marketing Expenses for Pharmaceutical Companies in Challenging Economic Times
- Category: Press Releases
- Published: Wednesday, 14 November 2012 00:52
The current poor economic conditions have driven many companies to take cost cutting measures to maintain profitability. Marketing is certainly one area of focus as companies look for more affordable and efficient ways to reach their customers.
During these turbulent economic times, pharmaceutical companies are also looking to gain efficiencies by seeking lower cost and more streamlined distribution channels to reach health care professionals and patients, especially as the sales force numbers continue to shrink. According to a March 2009 report published by consulting firm ZS Associates, the number of pharmaceutical reps decreased from 102,000 in 2007 to 92,000 in the first quarter of 2009. This number is expected to dip to as low as 75,000 by 2012.*
Viscira (http://www.viscira.com), a San Francisco based interactive and new-media company delivering innovative technology solutions to the life sciences industry, is responding to these challenges by leveraging electronic channels such as the web, email and mobile devices in new and compelling ways to enable life science clients to directly reach their target audiences.
Viscira provides a variety of innovative and differentiated interactive solutions ranging from next-generation 3D product animations and interactive medical case studies to web-based speaker training platforms and electronic journal reprints to deliver dynamic content to an industry that understands the importance of innovation. The company continues to expand its product offerings to respond to the growing demands of customers.
“Many of our technology solutions can be delivered directly to end users and can also be cost-effectively repurposed for multiple distribution channels to help maximize client investment.” explains Dave Gulezian, President and CEO of Viscira. “Moreover, we offer a number of unique products that can help make the pharma sales force more effective even if their overall numbers might be smaller.”
Further facilitating this shift is the growing acceptance and adoption of new technology and electronic communication by patients and healthcare professionals. In fact, the number of physicians who use the Internet and other technology to access pharmaceutical, biotech, and medical device information has grown to almost 90% of the total U.S. physician population.**
“The Internet and other new media channels are becoming increasingly important ways for myself and my colleagues to stay current on new developments in patient care,” says Dr. Anthony Padula, a leading rheumatologist practicing in the San Francisco Bay area. “However, the quality of the educational programs delivered through these channels must be very high if they are to be effective.”
Beyond providing innovative interactive products, Viscira takes a strategic approach when working with its clients by investing in fully understanding their marketing goals and objectives. This methodology allows the company to leverage its technology expertise, marketing savvy and scientific knowledge to obtain outstanding results.
Viscira’s strategic approach combined with its delivery of cutting-edge products has resulted in an impressive roster of clients for the company including Amgen, Johnson & Johnson, Genentech, Pfizer and Novartis. The company also boasts a medical advisory board comprised of leading healthcare practitioners from some of the country’s leading medical institutions.
*Drivers of Change to Pharmaceutical Commercial Models, ZS Associates, March 2009.
**Plugging into Physicians: Digital Marketing & Sales Strategies for Healthcare Companies, Manhattan Research, 2008.
Marketing Communications Manager - Viscira
Phone: (617) 429-0834